Skip to main content
PatientsReferrer
 
Request Appointment
Image
https://www.qscan.com.au/wp-content/uploads/2022/08/Dr-Erin-Gamble-website-1.png

Dr Erin
Bamford

BAppSc (MedSc), MPhtySt MD, FRANZCR
Specialties and interests
  • Musculoskeletal imaging
  • Image-guided musculoskeletal procedures
About

Dr Erin Bamford is a radiologist with Qscan Radiology Clinics. Her subspecialty is musculoskeletal imaging and procedures. Erin obtained her medical degree at Griffith University in 2014, graduating with distinction and receiving the Dean's Medallion for Academic Excellence and the Anatomy Prize. She completed her postgraduate training at the Princess Alexandra Hospital.

Before commencing medical training, Erin completed a Bachelor of Applied Science (Medical Science) at Queensland University of Technology in 2002 and Master of Physiotherapy Studies at the University of Queensland in 2005, after which she worked as a physiotherapist predominantly in orthopaedics and sports medicine.

Erin completed her subspecialty training with Qscan in 2022 and works as a consultant radiologist in our Brisbane locations.

Fellowships
  • Musculoskeletal Fellowship, Qscan Radiology Clinics, 2022

News & Articles

 

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.

Radiofrequency Ablation (RFA) for managing chronic pain

Radiofrequency ablation (RFA) is an interventional procedure performed by a high trained Radiologist under imaging gu

PSMA PET-CT Medicare Rebate

As of 1 July 2022, Medicare rebates are available for patients suffering from prostate cancer.

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.

Radiofrequency Ablation (RFA) for managing chronic pain

Radiofrequency ablation (RFA) is an interventional procedure performed by a high trained Radiologist under imaging gu

PSMA PET-CT Medicare Rebate

As of 1 July 2022, Medicare rebates are available for patients suffering from prostate cancer.